Find News

Filter articles

Showing 21 to 30 of 2294 results

Scientists want CRISPR regulation amid reports of foetus gene-editing


Scientists have urged policymakers to implement a regulatory framework governing the use of CRISPR technology in humans, following reports that a Chinese scientist has successfully created ‘edited’ twins.

CRISPR tech market to reach $1.72m by 2023: report


The global CRISPR technology market is expected to reach $1.72 million in value by 2023, up from 2018’s predicted figure of $562 million, according to a report released this month.

Life sciences partners join Saul Ewing’s Boston office


Saul Ewing Arnstein & Lehr has strengthened its Boston office with the addition of two life sciences partners from Hamilton, Brook, Smith & Reynolds.

Indivior loses battle over Suboxone generic


The US Court of Appeals for the Federal Circuit vacated a preliminary injunction against India-based Dr Reddy’s earlier this week, in a blow for addiction treatment drug producer Indivior.

Leo Pharma and PellePharm sign rare disease deal

Denmark, US22-11-2018

Denmark-based Leo Pharma and Californian rare disease company PellePharm have partnered to develop and commercialise therapies for rare forms of skin cancer.

EU court throws out catheter trademark appeal


The EU General Court has upheld a decision to deny Japanese medical device producer Asahi Intecc a trademark for a line of catheters it produces.

Indian court rules in Sanofi’s favour in trademark suit


The Delhi High Court has ruled against a company for its ‘near identical’ imitation of pharmaceutical company Sanofi’s name and trademarks.

Boston Scientific acquires BTG for $4.2bn

UK, US20-11-2018

Medical device manufacturer Boston Scientific today announced that it will acquire UK-based healthcare company BTG for $4.2 billion.

LSPN Europe 2018: Russian litigation and US second medical use

Russia, UK, US20-11-2018

The strategies of generic makers in Russia have changed dramatically over the past few years, according to Natalia Gulyaeva, partner at Hogan Lovells.

10x Genomics sued over cell research tools


Genome sequencing company 10x Genomics has been accused of infringing 11 patents covering cell research and analysis tools.

Showing 21 to 30 of 2294 results